Search for: "Boehringer Ingelheim, Inc." Results 21 - 40 of 155
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jan 2018, 12:30 pm by Tom Lamb
Boehringer Ingelheim Pharmaceuticals, Inc. is the drug company responsible for OFEV in the US. [read post]
29 Nov 2017, 3:29 am
In re Boehringer Ingelheim Pharmaceuticals, Inc., Serial No. 86852106 (November 27, 2017) [not precedential] (Opinion by Judge Frances Wolfson).The Board ignored applicant's feeble double entendre argument, but it agreed with applicant that the USPTO's evidence failed to show that the term "breathless" merely describes the subject services. [read post]
30 Dec 2016, 2:58 pm
Permission to appeal in patent cases - farewell to the Pozzoli approachGuest Kat Eibhlin Vardy recaps the case Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, [2016] EWCA Civ 1296. [read post]
22 Aug 2016, 1:05 pm by jromDLT
You may be entitled to compensation for your medical bills, lost wages, pain and suffering and other damages that can be pursued in a defective drug lawsuit against the manufacturer of Pradaxa, Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
5 Aug 2016, 2:10 pm by Tom Lamb
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention   (Posted by Tom Lamb at DrugInjuryWatch.com)   This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors Class of… [read post]
13 Jul 2016, 1:56 pm by Tom Lamb
About a month later, however, only those three diabetes drugs from Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
8 May 2016, 9:59 pm by Patent Docs
KG; Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
8 Jul 2015, 8:31 am by Katharyn Grant (US)
., Inc., 625 F.2d 1055 (3d Cir. 1980) (holding unique coloring of prescription drug capsule constituted protectable trade dress); Boehringer Ingelheim G.m.b.H. v. [read post]
16 Mar 2015, 9:23 am by CSSFIRM.COM
., Pfizer Inc., and Boehringer Ingelheim GmbH all have similar medications currently in development. [read post]
9 Mar 2015, 2:38 pm by The Public Employment Law Press
Litigation and Government Investigations at Boehringer Ingelheim Pharmaceuticals where she oversaw all U.S. litigation and government investigations. [read post]
4 Mar 2015, 1:32 pm by Morse, Barnes-Brown Pendleton
Last week, MBBP’s Scott Bleier attended a panel discussion hosted by the Johnson & Johnson Boston Innovation Center, which featured three corporate venture capitalists from Sanofi-Genzyme Bioventures, Boehringer Ingelheim Venture USA Inc. and Johnson & Johnson Development Corp. [read post]
5 Jun 2014, 7:06 am by Daniel Schwartz
 Boehringer Ingelheim Pharmaceuticals, Inc., which was decided just a few months before I started my career in employment law. [read post]